http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0230902-A8

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95b7ce95f4d6e92ddc85c1853764e54d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8be6a6c990669567cc455d32b00535e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a74fb86e09c449b3cf599ed7b482bde0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ab0bf527d7a3e5ba50b02e8390987539
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
filingDate 2001-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4e64be8b7d80a813a20edda60c90d12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b88d01eb84bb078867f406a4753ab70c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d87066f252ad3190ef2633136019330
publicationDate 2004-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0230902-A8
titleOfInvention Crystal forms of 1-[6-chloro-5-(trifluoromethyl)-2-pyridinyl]piperazine.hydrochloride
abstract The invention relates to crystal forms A and B of 1-[6-chloro-5-(trifluoromethyl)-2-pyridinyl]piperazine.hydrochloride (Org 12962), to methods for the preparation of those crystal forms and to pharmaceutical compositions comprising crystal form B useful in the treatment of depression, anxiety, obesity, or urinary incontinence.
priorityDate 2000-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9796408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231398275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497193
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227172108
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9796407

Total number of triples: 34.